Infervision Medical Technology
About Infervision Medical Technology
Infervision Medical Technology is a leading AI medical technology company established in 2016, dedicated to enhancing multi-disciplinary healthcare services through artificial intelligence. The company offers a comprehensive suite of AI-assisted software solutions designed to support physicians across the entire clinical workflow: from disease screening and diagnosis to patient treatment and management, and even research and development.
Their advanced platforms leverage deep learning technologies to analyze medical imaging data from various modalities, including DR, CT, and MRI. These solutions aim to improve diagnostic accuracy and efficiency for a wide array of conditions, such as various cancers, infectious diseases (e.g., tuberculosis, pneumonia, including COVID-19), cardiovascular diseases, cerebrovascular diseases (like strokes and intracranial hemorrhages), and trauma. Key product lines include InferRead® for diagnostic assistance, InferOperate® for surgical planning and intervention, InferCare® for patient health management, and InferScholar®/InferMartrix for medical research. Infervision’s products have received significant regulatory clearances, including FDA, CE, PMDA, UKCA, and NMPA, facilitating their adoption in major global markets.
Focus Areas
Business Intelligence
| Key Investors | CDH, Qiming Venture Partners, CCB Trust, Sequoia Capital, Goldman Sachs Asset Management, Z-Park Fund, Springhill Fund, Advantech Capital, Genesis Capital, Xianghe Capital Co. |
| Partnerships | SimonMed, Viz.ai, GE Healthcare (in China), NHS SBS framework, Peking Union Medical College Hospital, Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, Dalian Zhongshan Hospital, Beijing Tian Tan Hospital, Pärnu Hospital, Hospital Vall d'Hebron, NVIDIA |
| Technology | Deep learning technology, neural network-based medical imaging, computer vision, AI application management platform, AI data-mining research platform, AI clinical application platforms, InferMatrix (AI-enabled medical application platform), cloud-based and on-premise deployment options, NVIDIA's MONAI framework, NVIDIA's TensorRT-accelerated inference, Convolutional Neural Network (CNN) |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
Infervision's AI solutions are designed to significantly improve diagnostic accuracy and efficiency by detecting subtle anomalies and reducing missed diagnoses, thereby leading to earlier interventions and better patient outcomes, especially in time-sensitive conditions like stroke and lung cancer. Physicians benefit from comprehensive clinical support spanning screening, diagnosis, treatment planning, and follow-up, with quantitative and standardized reporting that includes detailed analytical information and comparisons with prior studies. The automation of routine tasks and highlighting of critical findings help reduce workload and burnout, allowing physicians to focus on complex cases and patient care. Furthermore, their platforms facilitate multi-specialty collaboration and empower physicians to engage in deep-learning analytical research, even with limited coding experience.
Infervision's solutions are built for seamless integration into existing medical workflows and Picture Archiving and Communication Systems (PACS). They have established strategic partnerships for integration with leading platforms such as ConcertAI's TeraRecon Eureka Clinical AI and the Viz.ai ecosystem, ensuring their AI capabilities can be easily incorporated into diverse healthcare environments.
What the Web Says
Infervision Medical Technology is an AI medical technology company founded in 2016, specializing in AI-driven platforms and tools for disease screening, diagnosis, intervention, treatment, patient management, and medical research. Their products, such as InferRead Lung CT.AI, have received FDA clearance and CE mark, and are used in over 380 hospitals globally, processing over 55,000 cases daily. The company emphasizes speed, workflow friendliness, and accuracy in its product development.
Overall: PositiveStrengths
- AI-driven platforms aid in quick and accurate diagnosis and treatment of diseases.
- Products like InferRead Lung CT.AI can improve diagnostic accuracy and reduce reading times for radiologists.
- Technology can identify early signs of disease and detect abnormalities that traditional methods might miss.
- Solutions are designed to be user-friendly and integrate into existing medical workflows.
- Infervision's AI has shown success in detecting early signs of lung cancer and diagnosing strokes more quickly and accurately.
- The company's products have received international regulatory clearances (FDA, CE, UKCA), expanding global accessibility.
Limitations
- No specific cons were found in the provided search results regarding Infervision Medical Technology's products or employer reviews from the requested sources (G2, Glassdoor, Capterra, Reddit, healthcare IT reviewers).
- Some search results for similarly named companies (Innervision, Infovision, Invision Health, InfoCision) showed mixed or negative employee reviews regarding work-life balance, pay, management, and job security, but these are not directly related to Infervision Medical Technology.
Based on reviews from: G2, Forbes, SourceForge, AITopTools, News Center, Slashdot
Last updated: 2026-07-18
Videos
News, demos, and interviews about Infervision Medical Technology.
Videos load interactively. If none appear, search YouTube for Infervision Medical Technology →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]